Pavan Cheruvu - Net Worth and Insider Trading

Pavan Cheruvu Net Worth

The estimated net worth of Pavan Cheruvu is at least $86,244 dollars as of 2024-11-05. Pavan Cheruvu is the CEO of Sio Gene Therapies Inc and owns about 180,426 shares of Sio Gene Therapies Inc (SIOX) stock worth over $86,244. Details can be seen in Pavan Cheruvu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pavan Cheruvu has not made any transactions after 2021-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Pavan Cheruvu

To

Pavan Cheruvu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pavan Cheruvu owns 1 companies in total, including Sio Gene Therapies Inc (SIOX) .

Click here to see the complete history of Pavan Cheruvu’s form 4 insider trades.

Insider Ownership Summary of Pavan Cheruvu

Ticker Comapny Transaction Date Type of Owner
SIOX Sio Gene Therapies Inc 2021-03-23 Chief Executive Officer

Pavan Cheruvu Latest Holdings Summary

Pavan Cheruvu currently owns a total of 1 stock. Pavan Cheruvu owns 180,426 shares of Sio Gene Therapies Inc (SIOX) as of March 23, 2021, with a value of $86,244.

Latest Holdings of Pavan Cheruvu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SIOX Sio Gene Therapies Inc 2021-03-23 180,426 0.48 86,244

Holding Weightings of Pavan Cheruvu


Pavan Cheruvu Form 4 Trading Tracker

According to the SEC Form 4 filings, Pavan Cheruvu has made a total of 2 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 100,000 shares on March 23, 2021, which cost Pavan Cheruvu around $248,000.

Insider Trading History of Pavan Cheruvu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pavan Cheruvu Trading Performance

GuruFocus tracks the stock performance after each of Pavan Cheruvu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pavan Cheruvu is 32.94%. GuruFocus also compares Pavan Cheruvu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pavan Cheruvu within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Pavan Cheruvu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Pavan Cheruvu

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.41 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.74 LIMIT LIMIT LIMIT LIMIT LIMIT

Pavan Cheruvu Ownership Network

Ownership Network List of Pavan Cheruvu

No Data

Ownership Network Relation of Pavan Cheruvu

Insider Network Chart

Pavan Cheruvu Owned Company Details

What does Sio Gene Therapies Inc do?

Who are the key executives at Sio Gene Therapies Inc?

Pavan Cheruvu is the Chief Executive Officer of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , 10 percent owner Roivant Sciences Ltd. , and Principal Financial Officer David W. Nassif .

Sio Gene Therapies Inc (SIOX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sio Gene Therapies Inc Insider Transactions

No Available Data

Pavan Cheruvu Mailing Address

Above is the net worth, insider trading, and ownership report for Pavan Cheruvu. You might contact Pavan Cheruvu via mailing address: C/o Axovant Sciences, Inc., 11 Times Square, 33rd Floor, New York Ny 10036.